NEW YORK (GenomeWeb News) — Biofortuna said today that it has received 510(k) clearance from the US Food and Drug Administration for its SSPGo HLA PCR kits.

The qualitative DNA-based kits are used to determine human leukocyte antigen alleles in low to intermediate resolution, and are designed for transplantation genotyping and identification of genes that may be associated with various genetic conditions, the UK-based company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.